Search by category - Any -Regulated informationInside informationNon-regulated information Search by year - Any -2024202320222021202020192018201720162015 30 April 2020 Biocartis Creates New Share Option Plan Regulated information 23 April 2020 Biocartis Announces Development of Idylla™ COVID-19 test Non-regulated information 22 April 2020 Biocartis Q1 2020 business update Inside information Regulated information 20 April 2020 Important Notice Regarding the Annual and Extraordinary Shareholders’ Meetings Regulated information 7 April 2020 Invitation to the Annual and Extraordinary Shareholders’ Meetings Regulated information 2 April 2020 Biocartis Announces Publication of 2019 Annual Report Regulated information 26 March 2020 Biocartis Announces Co-commercialization of the SeptiCyte® RAPID Test on Idylla™ (CE IVD) and Provides Update on COVID 19 Impact Regulated information 5 March 2020 Biocartis announces 2019 results and 2020 outlook Regulated information 5 March 2020 Biocartis Announces New Immuno-Oncology Project with Bristol-Myers Squibb Aimed at Registration of Idylla™ MSI test in China Non-regulated information 5 March 2020 Biocartis Creates New Share Option Plan & Cancels Outstanding Pool under 2018 Share Option Plan Regulated information Pagination First page « First Previous page ‹‹ … Page 11 Page 12 Page 13 Page 14 Current page 15 Page 16 Page 17 Page 18 Page 19 … Next page ›› Last page Last »